Penn researchers use honeybee venom toxin to develop a new tool for studying hy...(six other types of Kir channels. Th...),Health
Navigation Links
Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension
Date:9/17/2008
six other types of Kir channels.
The development of TPNLQ demonstrates that a highly specific inhibitor of potassium channels can be engineered. TPNLQ can now be used as a tool to prove the concept, in animal studies, that reducing salt reabsorption by plugging up renal Kir type 1 potassium channels is a potential new way to treat hypertension.
'/>"/>
| Contact: Karen Kreeger karen.kreeger@uphs.upenn.edu 215-349-5658 University of Pennsylvania School of Medicine Source:Eurekalert |
Related medicine news :
1. Johns Hopkins researchers suppress hunger hormone
2. Penn researchers identify natural tumor suppressor
3. Two U.S. Researchers Win Prestigious International Science Award
4. Researchers receive grant to study ways of preventing heart disease
5. Yerkes researchers create animal model of chronic stress
6. Surgical technique halts cell loss, Parkinsons researchers find
7. Millions face undiagnosed heart risk say researchers after mass screening
8. Superbug breast infections controllable in nursing mothers, UT Southwestern researchers find
9. Heart attack patients who stop statin risk death, say McGill researchers
10. UTMB researchers test new vaccine to fight multiple influenza strains
11. New method to overcome multiple drug resistant diseases developed by Stanford researchers
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 2Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 3Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 2Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 3Health News:Finding the Achilles' heel of cancer 2Health News:New model of skin cancer provides insights on second-most common type of cancer 2Health News:GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 2
[0] Emmy Award Winning Actress Debra Messing Visits Zimbabwe[0] Mechanism discovered by which body's cells encourage tuberculosis infection[0] Finding the Achilles' heel of cancer[0] New model of skin cancer provides insights on second-most common type of cancer[0] GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech
Other Medicine News:Health News:Stay Young with an Extended Warranty for Your Body 2Health News:Sister Red Cross Societies Help Each Other 2Health News:Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment 2Health News:Exploring the Use of Techniques From Neuroscience in Today's Marketing 2Health News:Exploring the Use of Techniques From Neuroscience in Today's Marketing 3Health News:ABC's Bob Woodruff to Be Recognized at National Academy of Neuropsychology 1st Annual Public Awareness Recognition Ceremony 2
Stay Young with an Extended Warranty for Your BodySister Red Cross Societies Help Each OtherAUDIO from Medialink and P&G: New Tools for Promoting Good Mouth HealthSchering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care EnvironmentExploring the Use of Techniques From Neuroscience in Today's MarketingABC's Bob Woodruff to Be Recognized at National Academy of Neuropsychology 1st Annual Public Awareness Recognition Ceremony
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 1iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 2iCRco Makes Inroads in Maritime Healthcare and Completes the First Two Installs on World Renowned Cruise Lines 55360 3Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 1Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 2Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 3Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 4Healthy San Francisco Enrollees Express High Levels of Satisfaction With Citys Health Access Program and Survey Shows Signs of Improved Access to Care 55355 5AIM Health Group Inc announces June 30 2009 financial results showing continued improvement in quarterly profits 55352 1AIM Health Group Inc announces June 30 2009 financial results showing continued improvement in quarterly profits 55352 2AIM Health Group Inc announces June 30 2009 financial results showing continued improvement in quarterly profits 55352 3AIM Health Group Inc announces June 30 2009 financial results showing continued improvement in quarterly profits 55352 4AIM Health Group Inc announces June 30 2009 financial results showing continued improvement in quarterly profits 55352 5
[0] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline[0] FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology[0] The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies
Other Medicine Technology:DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use 2DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use 3DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use 4DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use 5Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents 2Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents 3Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents 4Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |